Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 421

  • Showing results for galeazzi m. Search instead for Galleazzi M (1 item)
1.

Can balneotherapy modify microRNA expression levels in osteoarthritis? A comparative study in patients with knee osteoarthritis.

Giannitti C, De Palma A, Pascarelli NA, Cheleschi S, Giordano N, Galeazzi M, Fioravanti A.

Int J Biometeorol. 2017 Aug 7. doi: 10.1007/s00484-017-1420-3. [Epub ahead of print]

PMID:
28785809
2.

Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review.

Sota J, Rigante D, Lopalco G, Frediani B, Franceschini R, Galeazzi M, Iannone F, Tosi GM, Fabiani C, Cantarini L.

Rheumatol Int. 2017 Jul 27. doi: 10.1007/s00296-017-3775-5. [Epub ahead of print] Review.

PMID:
28752230
3.

Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study.

Colafrancesco S, Priori R, Valesini G, Argolini L, Baldissera E, Bartoloni E, Cammelli D, Canestrari G, Cantarini L, Cavallaro E, Cavalli G, Cerrito L, Cipriani P, Dagna L, Marchi G, Vita S, Emmi G, Ferraccioli G, Frassi M, Galeazzi M, Gerli R, Giacomelli R, Gremese E, Iannone F, Lapadula G, Lopalco G, Manna R, Mathieu A, Montecucco C, Mosca M, Piazza I, Piga M, Pontikaki I, Romano M, Rossi S, Rossini M, Ruscitti P, Silvestri E, Stagnaro C, Talarico R, Tincani A, Viapiana O, Vitiello G, Fabris F, Bindoli S, Punzi L, Galozzi P, Sfriso P.

Front Pharmacol. 2017 Jun 13;8:369. doi: 10.3389/fphar.2017.00369. eCollection 2017.

4.

Quality of life impairment in Behçet's disease and relationship with disease activity: a prospective study.

Fabiani C, Vitale A, Orlando I, Sota J, Capozzoli M, Franceschini R, Galeazzi M, Tosi GM, Frediani B, Cantarini L.

Intern Emerg Med. 2017 Jun 15. doi: 10.1007/s11739-017-1691-z. [Epub ahead of print]

PMID:
28620840
5.

Retroperitoneal fibrosis following a long-standing etanercept treatment in a spondyloarthritis patient.

Manganelli S, Giannitti C, Galeazzi M, Rossi M.

Joint Bone Spine. 2017 Jul 28. pii: S1297-319X(17)30115-X. doi: 10.1016/j.jbspin.2017.05.024. [Epub ahead of print] No abstract available.

PMID:
28600212
6.

What could we learn from the sub-analysis of a single nation cohort in a worldwide study? Lessons from the results observed in the Italian cohort of the GO-MORE trial.

Giacomelli R, Ruscitti P, Bombardieri S, Cuomo G, De Vita S, Galeazzi M, Mecchia M; Italian GO-MORE Investigators.

Clin Exp Rheumatol. 2017 Jul-Aug;35(4):623-629. Epub 2017 Jun 6.

PMID:
28598774
7.

Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema.

Fabiani C, Vitale A, Emmi G, Lopalco G, Vannozzi L, Bacherini D, Guerriero S, Favale RA, Fusco F, Franceschini R, Frediani B, Iannone F, Galeazzi M, Tosi GM, Cantarini L.

J Ocul Pharmacol Ther. 2017 May 30. doi: 10.1089/jop.2017.0034. [Epub ahead of print]

PMID:
28557602
8.

Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature.

Gentileschi S, Rigante D, Vitale A, Sota J, Frediani B, Galeazzi M, Cantarini L.

Clin Rheumatol. 2017 Jul;36(7):1687-1690. doi: 10.1007/s10067-017-3688-4. Epub 2017 May 23. Review.

PMID:
28536823
9.

IL-6 blockade in the management of non-infectious uveitis.

Lopalco G, Fabiani C, Sota J, Lucherini OM, Tosi GM, Frediani B, Iannone F, Galeazzi M, Franceschini R, Rigante D, Cantarini L.

Clin Rheumatol. 2017 Jul;36(7):1459-1469. doi: 10.1007/s10067-017-3672-z. Epub 2017 May 20.

PMID:
28528519
10.

Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries.

Codullo V, Iannone F, Sinigaglia L, Favalli EG, Sarzi-Puttini P, Atzeni F, Ferraccioli G, Gremese E, Carletto A, Giollo A, Govoni M, Bergossi F, Galeazzi M, Cantarini L, Salaffi F, Di Carlo M, Bazzani C, Pellerito R, Sebastiani M, Ramonda R, Lapadula G, Caporali R.

Clin Exp Rheumatol. 2017 Jul-Aug;35(4):660-665. Epub 2017 May 8.

PMID:
28516879
11.

Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet's disease.

Vitale A, Emmi G, Lopalco G, Fabiani C, Gentileschi S, Silvestri E, Gerardo DS, Iannone F, Frediani B, Galeazzi M, Lapadula G, Rigante D, Cantarini L.

Clin Rheumatol. 2017 Apr 11. doi: 10.1007/s10067-017-3627-4. [Epub ahead of print]

PMID:
28401434
12.

Cytokine Signatures in Mucocutaneous and Ocular Behçet's Disease.

Lopalco G, Lucherini OM, Lopalco A, Venerito V, Fabiani C, Frediani B, Galeazzi M, Lapadula G, Cantarini L, Iannone F.

Front Immunol. 2017 Feb 27;8:200. doi: 10.3389/fimmu.2017.00200. eCollection 2017.

13.

Baseline autoantibodies preferentially impact abatacept efficacy in patients with rheumatoid arthritis who are biologic naïve: 6-month results from a real-world, international, prospective study.

Alten R, Nüßlein HG, Mariette X, Galeazzi M, Lorenz HM, Cantagrel A, Chartier M, Poncet C, Rauch C, Le Bars M.

RMD Open. 2017 Feb 13;3(1):e000345. doi: 10.1136/rmdopen-2016-000345. eCollection 2017.

14.

Update on the Medical Management of Gastrointestinal Behçet's Disease.

Lopalco G, Rigante D, Venerito V, Fabiani C, Franceschini R, Barone M, Lapadula G, Galeazzi M, Frediani B, Iannone F, Cantarini L.

Mediators Inflamm. 2017;2017:1460491. doi: 10.1155/2017/1460491. Epub 2017 Jan 22. Review.

15.

The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy.

Vitale A, Rigante D, Lucherini OM, De Palma A, Orlando I, Gentileschi S, Sota J, Simpatico A, Fabiani C, Galeazzi M, Frediani B, Cantarini L.

Intern Emerg Med. 2017 Aug;12(5):605-611. doi: 10.1007/s11739-017-1622-z. Epub 2017 Feb 13.

PMID:
28194697
16.

Hydrostatic Pressure Regulates MicroRNA Expression Levels in Osteoarthritic Chondrocyte Cultures via the Wnt/β-Catenin Pathway.

Cheleschi S, De Palma A, Pecorelli A, Pascarelli NA, Valacchi G, Belmonte G, Carta S, Galeazzi M, Fioravanti A.

Int J Mol Sci. 2017 Jan 12;18(1). pii: E133. doi: 10.3390/ijms18010133.

17.

Do MicroRNAs have a key epigenetic role in osteoarthritis and in mechanotransduction?

De Palma A, Cheleschi S, Pascarelli NA, Tenti S, Galeazzi M, Fioravanti A.

Clin Exp Rheumatol. 2017 May-Jun;35(3):518-526. Epub 2017 Jan 4. Review.

PMID:
28079507
18.

The effect of body mass index on clinical response to abatacept as a first-line biologic for rheumatoid arthritis: 6-month results from the 2-year, observational, prospective ACTION study.

Mariette X, Alten R, Nüßlein HG, Galeazzi M, Lorenz HM, Cantagrel A, Chartier M, Poncet C, Rauch C, Le Bars M.

Joint Bone Spine. 2016 Dec 30. pii: S1297-319X(16)30210-X. doi: 10.1016/j.jbspin.2016.10.011. [Epub ahead of print]

PMID:
28043761
19.

The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases.

Fabiani C, Sota J, Tosi GM, Franceschini R, Frediani B, Galeazzi M, Rigante D, Cantarini L.

Clin Rheumatol. 2016 Dec 28. doi: 10.1007/s10067-016-3527-z. [Epub ahead of print]

PMID:
28032234
20.

Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study.

Fabiani C, Vitale A, Emmi G, Lopalco G, Vannozzi L, Guerriero S, Gentileschi S, Bacherini D, Franceschini R, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Clin Rheumatol. 2017 Jan;36(1):191-197. doi: 10.1007/s10067-016-3506-4. Epub 2016 Dec 16.

PMID:
27981463

Supplemental Content

Loading ...
Support Center